Tuesday, 19th September Victorian Comprehensive Cancer Centre Inaugural Research Conference 2017

Opening Remarks: Ricky Johnstone and Paul Omond

• Patterns of somatic mutation in cancer - Peter Campbell
• Telomere instability in cells with insufficient telomerase - Elizabeth Blackburn
• Reactivating tumour suppressor pathways to treat melanoma - Grant McArthur

• Metabolic regulation of immuno-oncology - Craig Thompson
• Identifying cells of origin of breast cancer - Jane Visvader
• Targeting BCL2 in blood cancers – successful translation into practice - Andrew Roberts

• Using genomics to understand cell of origin in leukemia - Charles Mullighan
• Preclinical models for personalised approaches in the treatment of childhood leukaemia - Richard Lock
• RNA sequencing to find cancer fusion genes and new cancer biology - Paul Ekert

• Making probability personal: identifying pathogenic variants and testing for them when it matters - John Burn
• The use of personalized DNA testing to guide screening for colorectal cancer - Mark Jenkins
• Predicting breast cancer incidence: determining what information is important - Robert MacInnis

Closing Remarks: Sean Grimmond

•     - Sean Grimmond

Some of the Palliative Care and Psycho-oncology sessions of the program will run in parallel. Please refer to session title to see which parallel stream it sits in.

Some of the Palliative Care and Psycho-oncology sessions of the program will run in parallel. Please refer to session title to see which parallel stream it sits in.

• Building a research program informed by clinical care - Eduardo Bruera
• Building a research platform for delivering supportive interventions to people living with cancer - Lidia Schapira

• Psychosocial issues in genomics - Phyllis Butow
• Pilot-testing of a decision aid for participants in whole genome screening and psychosocial impact of testing for polygenic breast cancer risk - Bettina Meiser
• When ethics, genetics and paediatrics collide: Investigating the impact of genetic testing, genetics-related service needs, and the acceptability of new genetics in childhood cancer - Claire Wakefield

• Managing multiple complex symptoms in palliative care: Building the evidence base - Patsy Yates
• What’s the future of prognosis in palliative care? - Paul Glare
• Palliative care as a standard part of quality cancer care - what will it take? - Jennifer Philip

• Between the motion and the act: new insights into the cancer-suicide link - Justin Dwyer

• Empowering the clinician-patient-family TRIO: clinical guidelines and online training to manage and enhance family involvement in cancer consultations - Ilona Juraskova
• Talking to children about parental cancer: development of an intervention to support parents with cancer who have young children - Lesley Stafford

• Focus on bereavement : outcomes, risk factors and the health professional - Brian Kelly
• Interventions for family caregivers: an overview of the state of the science - Peter Hudson

Eduardo Bruera

Lidia Schapira

Brian Kelly

Steve Ellen

Consumer (TBC)

Closing Remarks: Jenny Phillips and Penelope Schofield

Opening Remarks: Fergus Kerr and Natasha Stork

• Chimeric antigen receptor modified T cells for B cell malignancies - Stan Riddell
• Intratumoral inflammation modifies the immunopeptidome in melanoma - Jonathan Cebon
• Tumor immunoevasion by conversion of effector NK cells into type 1 innate lymphoid cells - Mark Smyth
• New strategies for enhancing CAR T cell cancer therapy - Phil Darcy
• Atypical chemokine receptor 4 restrains anti-tumour CD8⁺ T cell responses in a breast cancer model - Shaun McColl

• (This presentation will not be recorded) Mechanisms of immune evasion and metastasis in colorectal cancer - Eduard Batlle
• (This presentation will not be recorded) Tumour inherent IFNs: Impact on dormancy, prognosis and therapeutic sensitivity - Belinda Parker
• The biomechanics of the microenvironment and its dysregulation in cancer - Michael Samuel
• Transient tissue ‘priming' via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasis: insights from intravital imaging. - Paul Timpson
• (This presentation will not be recorded) Cancer associated fibroblasts in bowel cancer - Dan Worthley
• (This presentation will not be recorded) Tumours and their microenvironment - Therapeutically targeting reciprocal interactions - Matthias Ernst

• Gut microbiome and metabolites and Western lifestyle diseases - Charles Mackay
• Our microbiome and cancer - Paul Johnson
• Discovery and development of therapy for cancer cachexia - Nick Hoogenraad
• Stress remodels the tumour microenvironment:  the impact on cancer progression - Erica Sloan
• The protective role of an innate immune molecule in gastric B cell lymphomagenesis due to chronic Helicobacter infection - Richard Ferrero
• Hdac3 regulates lipid oxidation in the intestinal epithelium - John Mariadason

Closing Remarks: Matthias Ernst

•     - Matthias Ernst

Opening: Arlene Wake and Kerry O'Donovan

• Development and implementation of end of treatment nurse consultations for women with breast cancer - Jo Armes
• The women’s wellness after cancer program: enhancing quality of life for women after cancer - Debra Anderson

• Demoralization - a common clinical disorder in patients and their families in oncology and palliative care - David Kissane
• Exercise medicine for cancer - Prue Cormie
• Cancer pain and its treatment with opioids: the detrimental link with innate immune-mediated inflammation - Andrew Somogyi

• Teleoncology, telenursing and tele-trials: evolution of tele health approach for treatment of rural, regional and rare cancer patients - Abhishek Joshi
• Digital care: transforming personal health - Trish Livingston
• Support from afar: The application of telemedicine to nutrition based cancer survivorship initiatives - Anna Boltong

• The RAGE project: implementing diagnostic pathways for gastrointestinal cancers - Jon Emery
• Development of a care complexity index for use in ambulatory settings by cancer nurses - Mei Krishnasamy
• eSMART: Using eHealth to predict those at risk of experiencing chemotherapy-induced symptoms - Jo Armes

Closing Remarks: Michael Green 

Opening remarks: Sue Matthews and Nicole Livingstone (Via Video)

• Breast Surgery - so what's new? - Cathie Poliness
• The role of sentinel lymph assessment in gynaecological cancer - Orla McNally
• Practice changing advances in systemic therapy for gynaecological cancer - Linda Mileshkin
• Tumour size, lympho-vascular invasion and metastasis: A clinical perspective - Kailash Naryan

• Estrogen receptor positive luminal progenitors may underlie high risk of ER+ breast cancers in nulliparous women - Kara Britt
• Cervical cancer prevention, everything is changing - Marion Saville
• The prevention of Uterine and Ovarian cancer - David Wrede
• RANK ligand as a target for breast cancer prevention in BRCA1 mutation carriers - Geoffrey Lindeman

• Life after cancer: maximising future fertility - Kate Stern
• Mental health of women with cancer – trauma, identity and maternity - Louise Newman
• Sex and relationships after cancer - Wendy Vanselow
• Social Distress in Women with Cancer : implications for co-creative supportive care - Lynette Joubert

• Internet-based sex therapy for breast cancer survivors: results of a randomized controlled trial - Neil Aaronson
• Managing menopausal symptoms after cancer: What works and what doesn’t? - Martha Hickey
• Early endometrial cancer survivorship clinic - Danielle Carpenter
• Survivorship care plans (SCPs) – what do survivors of gynaecological cancer want? - Nicole Kinnane

Closing Remarks: David Wrede

•     - David Wrede